BCCP Practice Test

Board Certified Cardiology Pharmacist Mock Exam

📝 Quiz Guide:

Questions: 30 High-Level Clinical Questions.
Time Limit: 45 Minutes.
Passing Score: 70% (21 correct answers).
Content: CV Therapeutics, EBM, & Guidelines.
PDF: Download the full Q&A PDF after completing the quiz.

Progress: 1/30 45:00

Quiz Results

0 / 30

BCCP Exam Guide & Details

Board Certified Cardiology Pharmacist (BPS)

What is the BCCP? The BCCP credential validates advanced expertise in cardiology pharmacotherapy, covering acute and chronic cardiovascular conditions, device therapy, anticoagulation, and complex clinical practice.

1. BCCP Exam Format

Total Questions	175 (150 scored + 25 unscored pretest)
Duration	4 Hours
Mode	Computer-based at Pearson VUE
Exam Windows	Twice per year (Spring & Fall)
Scoring	Scaled 200–800 (Passing Score ~500)

2. Eligibility Requirements

To sit for the exam, you must have a current, unrestricted pharmacist license and meet ONE of the following pathways:

Pathway A (Residency)

PharmD Degree
Completion of PGY-1 Residency AND
PGY-2 Cardiology Residency (ASHP-accredited)

Pathway B (Experience)

PharmD or BPharm degree
4 Years of post-licensure practice experience.
At least 50% of time must be spent in cardiology activities (CVICU, HF Clinic, Anticoagulation, etc.).

3. BCCP Content Outline (Syllabus)

Domain 1: Patient Care & Clinical Knowledge (55–65%)

This is the largest domain. You must master guidelines and pharmacotherapy for:

Coronary Artery Disease

Stable Angina, ACS (STEMI/NSTEMI)
PCI Management, DAPT
Secondary Prevention

Heart Failure

HFrEF/HFpEF Guidelines
GDMT (ARNI, SGLT2, Beta-blockers)
Cardiorenal Syndrome

Arrhythmias

AFib/Flutter, VT/SVT
Antiarrhythmics, Rate Control
Ablation & Cardioversion

Anticoagulation

DOACs, Warfarin, Heparins
VTE, Stroke Prevention
Reversal Agents & HIT

Dyslipidemia

Statins, Ezetimibe, PCSK9i
ASCVD Risk Assessment
Guideline-based therapy

Hypertension

Resistant HTN
Hypertensive Emergencies
Secondary HTN

Cardiac Devices/Structural

Pacemakers, ICDs, LVADs
Valve Disease (TAVR)
Endocarditis

Pulmonary/Transplant

Pulmonary HTN (PAH) drugs
Transplant Immunosuppression
Rejection management

Domain 2: Practice Management (15–25%)

Operations: Cardiac Rehab, Anticoagulation Clinics, HF Disease Management.
Safety: Care transitions, Protocols/Pathways, Population Health.

Domain 3: Evidence & Guidelines (10–20%)

Guidelines: ACC/AHA, ESC, CHEST, ISHLT.
Evidence: Biostatistics, Landmark Trials (PARADIGM-HF, DAPA-HF, etc.).

Domain 4: Public Health (5–10%)

ASCVD risk reduction
Smoking cessation & Obesity management
Vaccinations in HF patients

4. High-Yield Topics (Must Know)

ACS Guideline Therapy
HFrEF GDMT (4 Pillars)
AFib Anticoagulation (CHA2DS2-VASc)
DOAC Dosing Nuances
PCI Antithrombotic Regimens
Arrhythmia Algorithms (ACLS)
Advanced HF (LVAD/Transplant)
Pulmonary HTN Classes